Third Rock Ventures V, L.P. 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:15 pm Sale | 2026-06-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | Third Rock Ventures V, L.P. | 6,280,525 13.100% | -854,708 (-11.98%) | Filing |
| 2025-02-13 4:15 pm Purchase | 2024-12-31 | 13G | RAPPORT THERAPEUTICS INC RAPP | Third Rock Ventures V, L.P. | 7,135,233 19.500% | 7,135,233 (New Position) | Filing |